Benavent, MartaSastre, JavierGarcía Escobar, IgnacioSegura, AngelCapdevila, JaumeCarmona, AlbertoSevilla, IsabelAlonso, TeresaCrespo, GuillermoGarcía, LourdesCanal, Neusde la Cruz, GuillermoGallego, Javier2024-10-232024-10-232021-01-30http://hdl.handle.net/10668/17070https://hdl.handle.net/20.500.12105/25288Background and objective: Patient-reported outcome measures can provide clinicians with valuable information to improve doctor-patient communication and inform clinical decision-making. The aim of this study was to evaluate the physician-perceived utility of the QLQ-GINET21 in routine clinical practice in patients with gastrointestinal neuroendocrine tumours (GI-NETs). Secondary aims were to explore the patient, clinician, and/or centre-related variables potentially associated with perceived clinical utility. Methods: Non-interventional, cross-sectional, multicentre study conducted at 34 hospitals in Spain and Portugal (NCT02853422). Patients diagnosed with GI-NETs completed two health-related quality of life (HRQoL) questionnaires (QLQ-C30, QLQ-GINET21) during a single routine visit. Physicians completed a 14-item ad hoc survey to rate the clinical utility of QLQ-GINET21 on three dimensions: 1)therapeutic and clinical decision-making, 2)doctor-patient communication, 3)questionnaire characteristics. Results: A total of 199 patients at 34 centres were enrolled by 36 participating clinicians. The highest rated dimension on the QLQ-GINET21 was questionnaire characteristics (86.9% of responses indicating "high utility"), followed by doctor-patient communication (74.4%), and therapeutic and clinical decision-making (65.8%). One physician-related variable (GI-NET patient volume > 30 patients/year) was associated with high clinical utility and two variables (older age/less experience treating GI-NETs) with low clinical utility. Conclusions: Clinician-perceived clinical utility of QLQ-GINET21 is high. Clinicians valued the instruments' capacity to provide a better understanding of patient perspectives and to identify the factors that had the largest influence on patient HRQoL.engVoRhttp://creativecommons.org/licenses/by/4.0/Neuroendocrine tumorsHealth-related quality of lifeQLQ-GINET21 questionnaireCommunicationClinical utilityPhysiciansTumores neuroendocrinosCalidad de VidaComunicaciónMédicosAgedCross-Sectional StudiesFemaleGastrointestinal NeoplasmsHumansMaleMiddle AgedNeuroendocrine TumorsPhysiciansPortugalSpainYoung AdultAttitude of Health PersonnelQuality of LifeQuestionnairesCommunicationHospitalsAttribution 4.0 International335162111913810.1186/s12955-021-01688-x1477-7525Health and Quality of Life Outcomesopen access